SESSION 1 SCHEDULE
Wednesday
SESSION 1: HEMODIALYSIS ACCESS - PART 1
Moderators:TBD
x
7:50 AM - 7:59 AM Introduction
 
PART 1A: ACCESS PLANNING, DYSFUNCTIONAL FISTULAS AND CENTRAL VENOUS CATHETERS
Moderator(s): TBD  
8:00 AM - 8:10 AM Results Of The Dialysis Access Consortium: Where Do We Go From Here?
 
8:11 AM - 8:21 AM Does Physical Examination Have A Role In The Planning And Evaluation Of Hemodialysis Access?
 
8:22 AM - 8:32 AM Update On Ultrasound Imaging For Hemodialysis Access
 
8:33 AM - 8:43 AM Fundamentals Of Angiographic Evaluation Of AV Access
 
8:44 AM - 8:54 AM Facilitating Endovascular Access Procedures Using Flouro Trace
 
8:55 AM - 9:05 AM Management Of The Immature Fistula
 
9:06 AM - 9:16 AM Salvaging The Unsalvageable Fistula
 
9:17 AM - 9:27 AM Dialysis Catheters Are Bad News
 
9:28 AM - 9:38 AM Catheters Donít Kill Patients
 
9:39 AM - 9:59 AM Panel Discussion
10:00 AM - 10:20 AM Break / Visit Exhibits
PART 1B: MANAGEMENT OF CENTRAL VENOUS PROBLEMS
Moderator(s): TBD / TBD  
10:21 AM - 10:31 AM Pathophysiology Of Fibrin Sheath Development
 
10:32 AM - 10:42 AM Removal Of Embedded Catheters
 
10:43 AM - 10:53 AM Catheter Exchange Procedures
 
10:54 AM - 11:04 AM Catheter-Related Central Venous Stenosis
 
11:05 AM - 11:15 AM Pacemaker/Defibrillator Related Central Venous Stenosis
 
11:16 AM - 11:26 AM Power Wire For Central Venous Stenoses
 
11:27 AM - 11:37 AM Use Of The Peripheral Cutting Balloon For Treatment Of Cephalic Arch Stenosis Associated With Brachiocephalic Fistulas
 
11:38 AM - 11:48 AM Fatal Complications Of SVC Angioplasty
 
11:49 AM - 12:10 PM Panel Discussion
12:10 PM - 1:05 PM Lunch Break / Visit Exhibits
END OF SESSION 1
 
SESSION 2 SCHEDULE
Wednesday
SESSION 2: HEMODIALYSIS ACCESS - PART 2
Moderators:TBD
x
PART 2A: HEMODIALYSIS ACCESS COMPLICATIONS / THROMBECTOMY PROCEDURES
Moderator(s): TBD / TBD  
1:05 PM - 1:15 PM Surgical vs. Percutaneous Thrombectomy: Which Is Best?
 
1:16 PM - 1:26 PM Techniques For Percutaneous Thrombectomy
 
1:27 PM - 1:37 PM Management Of Arterial Embolization During Percutaneous Thrombectomy Of Hemodialysis Grafts And Fistulas
 
1:38 PM - 1:43 PM Debate: Should Interventionalists Do Surgery: Pro
 
1:44 PM - 1:49 PM Debate: Should Interventionalists Do Surgery: Con
 
1:50 PM - 2:00 PM Vascular Access Hemorrhagic Deaths Among Hemodialysis Patients
 
2:01 PM - 2:11 PM Are Antiplatelet Drugs Or Anticoagulation Ever Indicated To Maintain Access Patency?
 
2:12 PM - 2:32 PM Panel Discussion
2:33 PM - 2:55 PM Break / Visit Exhibits
PART 2B: UPDATE ON NEW TECHNOLOGIES (5 MINUTE TALKS)
Moderator(s): TBD / TBD  
2:56 PM - 3:01 PM Topical rThrombin For Wound Hemostasis
 
3:02 PM - 3:07 PM Role Of Heparin Bonded ePTFE Grafts In Dialysis Access
 
3:08 PM - 3:13 PM Preliminary Experience With The Duraspan Hemodialysis Catheter
 
3:14 PM - 3:19 PM Recombinant Human Elastase For Improved Vascular Access
 
3:20 PM - 3:30 PM Panel Discussion
PART 2C: IMPORTANT TOPICS IN VASCULAR ACCESS
Moderator(s): TBD / TBD  
3:31 PM - 3:41 PM Optimizing Hemodialysis Cannulation Methods: Role Of Buttonhole Cannulation
 
3:42 PM - 3:52 PM Clinical Practice Guidelines For Hemodialysis Access
 
3:53 PM - 4:03 PM Reimbursement For Vascular Access: What Does The Future Hold?
 
4:04 PM - 4:14 PM Vascular Access Surveillance And The CMS MAT-V551 Requirement
 
4:15 PM - 4:25 PM Radial-to-Cephalic Arteriovenous Fistulas As A Method Of Choice In Children And Adolescents
 
4:26 PM - 4:36 PM Perfect Dialysis Access Graft: Are We There Yet?
 
4:37 PM - 4:47 PM Ischemic Monomelic Neuropathy
 
4:48 PM - 5:10 PM Panel Discussion
5:10 PM - 5:10 PM Adjourn
END OF SESSION 2
 
SESSION 3 SCHEDULE
Wednesday
SESSION 3: NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE - PART 1
xxxx
Moderators:TBD
x
12:30 PM - 12:40 PM Opening Remarks
 
12:40 PM - 1:40 PM Case Studies: Clinical Presentation
  Presenters(s):Hazim J. Safi, MD  
1:40 PM - 1:55 PM What Imaging Wonít Tell Us About Aortic Disease
 
1:55 PM - 2:10 PM Genetic Disorders: Implications And Testing Efforts
 
2:10 PM - 2:25 PM Proximal Dissections: Acute Treatment Objectives And Long-Term Results
 
2:25 PM - 2:40 PM Surgical Education In The Era Of Rapidly Developing New Technologies
 
2:40 PM - 2:55 PM Pure Endovascular TAA Repair Techniques And Future
 
2:55 PM - 3:10 PM Contrast Between Open And Endovascular Repair Of Thoracoabdominal Aneurysms
 
3:10 PM - 3:25 PM Elephant Trunk Technique For The Treatment Of Extensive Thoracic Aortic Aneurysms
 
3:25 PM - 3:40 PM Spinal Cord Protection For TAA Repair
 
3:40 PM - 3:55 PM Endovascular Approaches To Aortic Arch Disease
 
3:55 PM - 4:15 PM Break
END OF SESSION 3
 
SESSION 4 SCHEDULE
Wednesday
SESSION 4: NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE - PART 2
xxxx
Moderators:TBD
x
4:15 PM - 6:00 PM Follow-up Case Studies: Management And Outcome
  Presenters(s):Hazim J. Safi, MD  
6:00 PM - 6:00 PM Adjourn. New Horizons in Cardiovascular Surgery continues on Thursday morning in the Grand Ballroom, 3rd floor.
END OF SESSION 4
 
SESSION 5 SCHEDULE
Wednesday
SESSION 5: ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 1
xxxx
Moderators:TBD
x
8:00 AM - 8:09 AM Welcoming Remarks
 
8:10 AM - 8:19 AM How To Identify The Best Patients For Endovenous Thermal Ablation
 
8:20 AM - 8:29 AM Which Patients Are Not Suitable For Endovenous Thermal Ablation?
 
8:30 AM - 8:39 AM Generating The Venous Map With Duplex Ultrasound
 
8:40 AM - 8:49 AM Great Saphenous vs. Small Saphenous Vein Ablation: Similarities And Differences Of Procedure
 
8:50 AM - 8:59 AM Endovenous Thermal Ablation: How I Choose Between RF Or Laser
 
9:00 AM - 9:09 AM Catheter-Directed Foam Sclerotherapy Treatment Of Saphenous Vein Incompetence
 
9:10 AM - 9:19 AM Lessons Learned After 3,000 Endovenous Ablations
 
9:20 AM - 9:35 AM Panel Discussion
9:36 AM - 9:45 AM Fire, Foam, And Knife For Varicose Veins: What Have Prospective Randomized Clinical Trials Taught Us?
 
9:46 AM - 9:55 AM What Studies Are Needed To Help Vein Doctors Treat Patients Better?
 
9:56 AM - 10:05 AM Preservation Of The Saphenous Vein In Patients With Varicose Veins
 
10:06 AM - 10:15 AM The CHIVA Approach To Varicose Vein Treatment
 
10:16 AM - 10:25 AM Matrix Metalloproteinases And Varicose Veins
 
10:26 AM - 10:35 AM Current Information On The Development And Treatment Of Venous Ulcers
 
10:36 AM - 10:45 AM How To Treat Ascending GSV Superficial Thrombophlebitis
 
10:46 AM - 10:54 AM Ileofemoral Venous Reflux And Obstruction: Diagnosis And Treatment
 
10:55 AM - 11:04 AM Venous Stenting: When, Where, Whom, How?
 
11:05 AM - 11:14 AM Deep Vein Considerations During Superficial Venous Treatment
 
11:15 AM - 11:24 AM The Future Of Venous Imaging: Will It Be Duplex Ultrasound, MRV, Or CTV?
 
11:25 AM - 11:34 AM Pelvic Venous Syndromes
 
11:35 AM - 11:44 AM Are Surgeons Letting Vein Care Slip Away?: Are Phlebologists Taking Over?
 
11:45 AM - 12:00 PM Panel Discussion
12:00 PM - 12:30 PM Lunch Break
END OF SESSION 5
 
SESSION 6 SCHEDULE
Wednesday
SESSION 6: ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 2
xxxx
Moderators:TBD
x
12:30 PM - 12:39 PM DVT Update: Current Recommendations For Treatment And Prophylaxis
 
12:40 PM - 12:49 PM Current Data On Radiofrequency Ablation With The ClosureFAST Catheter
 
12:50 PM - 12:59 PM Venous Laser Updates: New Wavelength Or Fibers?
 
1:00 PM - 1:09 PM Management Of The Anticoagulated Patient Who Needs Endovenous Ablation And Phlebectomy
 
1:10 PM - 1:19 PM Phlebectomy, Trivex, Or Sclerotherapy For Bulging Varicose Vein Tributaries?
 
1:20 PM - 1:29 PM Foam vs. Liquid Sclerotherapy In The Management Of Varicose Veins
 
1:30 PM - 1:39 PM Considerations For Treatment Of Infrapopliteal Deep Venous Thrombosis
 
1:40 PM - 1:49 PM Thrombotic Complications Of Endovenous Therapy For Varicose Veins
 
1:50 PM - 1:59 PM Thrombophilia: When To Order? What To Order? How To Treat And For How Long?
 
2:00 PM - 2:09 PM Should Adjuvant Procedures Be Performed At The Same Time As Endothermal Ablation?: Evidence Based
 
2:10 PM - 2:19 PM When Should Perforators Be Considered For Treatment?
 
2:20 PM - 2:29 PM Recurrent Varicose Veins: Can They Be Prevented? Can They Be Treated Effectively?
 
2:30 PM - 2:39 PM Role Of Laser vs. Sclerotherapy For Spider Telangiectasias?
 
2:40 PM - 2:49 PM Management Of Venous Malformations: Cut, Cook, Squirt?
 
2:50 PM - 3:00 PM Complications Of Foam Sclerotherapy: What I Have Witnessed
 
3:00 PM - 3:10 PM Establishing VTE Protocols For Prevention And Intervention
 
3:10 PM - 3:20 PM Building Your DVT Practice
 
3:20 PM - 3:50 PM Ask The Panel
  Panelist(s): Jose I. Almeida, MD, FACS, RVT / Lowell S. Kabnick, MD, FACS, FACPh / Ronald G. Bush, MD / Edward G. Mackay, MD / Thomas F. O'Donnell, Jr., MD / Peter F. Lawrence, MD / Peter J. Pappas, MD / Peter H. Lin, MD  
3:50 PM - 3:50 PM Adjourn
END OF SESSION 6
 
SESSION 7 SCHEDULE
Wednesday
SESSION 7: WOUNDS - PART 1
Moderators:TBD
x
8:00 AM - 8:10 AM Opening Remarks
 
PART 1A: NEW CONCEPTS IN WOUND CARE
Moderator(s): TBD  
8:10 AM - 8:20 AM Effect Of Different Frequencies Of Tensile Strain On Human Dermal Fibroblast Proliferation And Survival: Implication For The Practical Use
 
8:20 AM - 8:30 AM Discussion
8:30 AM - 8:40 AM The Use Of Skin Perfusion Pressure (SPP) With Pulse Volume Recording (PVR) To Accurately Assess Micro And Macro Circulation- Predicting Wound Healing
 
8:40 AM - 8:50 AM Discussion
8:50 AM - 9:00 AM Calciphylaxis And Martotell's Ulcer Need Fast Track Surgical Treatment
 
9:00 AM - 9:10 AM Discussion
9:10 AM - 9:20 AM Charged Polystyrene Microspheres: A New Technology For Treating Hard To Heal Chronic Wounds
 
9:20 AM - 9:30 AM Discussion
9:30 AM - 9:40 AM Autologous Platelet-Rich Fibrin Membrane In The Treatment Of Patients With Chronic Lower Extremity Ulcers
 
9:40 AM - 9:50 AM Discussion
9:50 AM - 10:00 AM Panel Discussion
10:00 AM - 10:30 AM Break / Visit Exhibits
PART 1B: MEETINGS SUMMARY
Moderator(s): TBD  
10:30 AM - 11:00 AM Best From WUWHS Meeting 2008
 
11:00 AM - 11:15 AM Discussion
11:15 AM - 11:45 AM Best From DFCON Meeting
 
11:45 AM - 12:00 PM Discussion
12:00 PM - 1:00 PM Lunch Break
END OF SESSION 7
 
SESSION 8 SCHEDULE
Wednesday
SESSION 8: WOUNDS - PART 2
Moderators:TBD
x
PART 2A: WOUND HEALING SOCIETIES
Moderator(s): TBD  
1:00 PM - 1:10 PM Introducing The Swiss Association for Wound Care (SAfW)
 
PART 2B: EVIDENCE BASED MEDICINE IN WOUND CARE
Moderator(s): TBD  
1:10 PM - 1:20 PM An Overview Of Level 1 Evidence From Cochrane Systematic Reviews On Systemic Wound Care
 
1:20 PM - 1:30 PM Discussion
1:30 PM - 1:40 PM Effectiveness Of Iodine In Wound Care: A Systematic Review
 
1:40 PM - 1:50 PM Discussion
1:50 PM - 2:00 PM Applying Evidence-Based Wound Healing To Difficult Chronic Wounds
 
2:00 PM - 2:10 PM Discussion
2:10 PM - 2:20 PM Evidence Informed Practice: A New Approach To Evidence Based Medicine
 
2:20 PM - 2:30 PM Discussion
2:30 PM - 3:00 PM Break / Visit Exhibits
PART 2C: CHALLENGES OF INTERDISCIPLINARY WOUND TEAMS
Moderator(s): TBD  
3:00 PM - 3:10 PM How To Get The Interdisciplinary Team To Talk And To Work In The Clinic
 
3:10 PM - 3:20 PM The Challenges Of An Open Access Interdisciplinary Foot Clinic And How To Overcome Them
 
3:20 PM - 3:30 PM The Role Of The Dermatologist In The Interdisciplinary Wound Team
 
3:30 PM - 3:40 PM The Role Of The Orthopedic Surgeon In The Interdisciplinary Wound Team
 
3:40 PM - 3:50 PM The Role Of The Vascular Surgeon In The Interdisciplinary Wound Team
 
3:50 PM - 4:00 PM The Role Of The Diabetologist In The Interdisciplinary Wound Team
 
4:00 PM - 4:20 PM Panel Discussion
PART 2D: VASCULAR INTERVENTIONS IN WOUND CARE
Moderator(s): TBD  
4:20 PM - 4:30 PM Debate: Balloon Angioplasty Is First Choice In All Wound Patients Suffering From Critical Limb Ischemia
 
4:30 PM - 4:40 PM Debate: Balloon Angioplasty Is Not First Choice In All Wound Patients Suffering From Critical Limb Ischemia
 
4:40 PM - 4:50 PM Discussion
4:50 PM - 5:00 PM Debate: Endovenous Ablation Is The Best Choice For Prevention Of Recurrent Venous Stasis Ulcers
 
5:00 PM - 5:10 PM Debate: Endovenous Ablation Is Not The Best Choice For Prevention Of Recurrent Venous Stasis Ulcers
 
5:10 PM - 5:20 PM Discussion
5:20 PM - 5:30 PM Closing Remarks
 
END OF SESSION 8